Abstract The large-conductance Ca
iberiotoxin blockade [47] , γ1 (also named LRRC26) makes channels resistant to mallotoxin activation [3] , β2 produces MaxiK channels that inactivate with time [84] , β3b produces channels with very fast inactivation producing currents that appear to activate fast and rectify [81, 89] , β1 increases Ca 2+ / voltage sensitivity when free Ca 2+ facing the inside of the channel is beyond 1 μM [45], while γ1-γ4 produces channels with increased voltage sensitivity even without Ca 2+ [91, 92] . Functional diversity of MaxiK channels is also conferred by alternative splicing of both α-and β-subunit mRNAs and by posttranslational modifications like phosphorylation and lipidation [1, 76, 99] .
In spite of its ubiquitous expression, the genetic ablation of MaxiK α-subunit in mice was not lethal, indicating that animals developed compensatory mechanisms to substitute for MaxiK potential vital function in organs where it is normally expressed and/or that MaxiK is not essential to sustain life, but rather, it may serve to fine-tune numerous body functions. In line with this view, more and more reports show MaxiK multiple physiological roles and involvement in a wide variety 
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"calcium bowl"
-catenin Amino acid sequence ending with QEERL corresponds to "insertless" hSlo; numbering starts at the third methionine (M3) (NCBI no. U11058). Highlighted are three possible start sites M1-M3 [83] , the seventransmembrane domains S0-S6, the pore region (selectivity filter in italics), the whole C-terminus, the regulator of K + conductance (RCK) domains 1 (RCK1; gray) and 2 (RCK2; pink), the calcium bowl, export signals (dashed double arrows, yellow), and examples of regions reported to date to be involved in direct or indirect protein interactions. For a complete list of interacting proteins and references, see Table 1 . For clarity, interacting sequences in Table 1 that include large portions of the protein were omitted in this figure. Arrows mark the position of the gliomaspecific 33-aa splice insert (red) upstream a 29-aa splice insert (gray), of the 59-aa splice insert encoded by the STREX exon, of the 27-aa splice insert known as ALCOREX [57] , and of the 50-aa C-terminal exon (italics) named after the last three amino acids, DEC. Three C-terminal isoforms are shown; the sequences of the DEC containing isoform correspond to the mouse brain isoform, mbr5 [66] . For the crystal structure of the Cterminus, see [96] of diseases. In this respect, the lack of the α-subunit produces body deficiencies that, although not fatal, on the long run, decrease the quality of life. For example, mice lacking the α-subunit suffer from incontinence, erectile dysfunction, hypertension, altered circadian rhythm, and age-dependent hearing deficiencies [48, 49, 62, 63, 86] .
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MaxiK cellular compartmentalization
Immunomapping or electrophysiological methods indicate that in most cells, MaxiK channels are expressed at the plasma membrane with adult cardiomyocytes being an interesting exception. In addition to its plasma membrane targeting, MaxiK channels can also localize to intracellular organelles like the endoplasmic reticulum, nucleus, and mitochondria ( Fig. 2) [67, 68, 70, 90] . The latter opens the tantalizing possibility that MaxiK channels might play a role in regulating mitochondria function and, consequently, cell death.
What are the intrinsic MaxiK signals targeting the channel to different cellular compartments or organelles? This is an active line of research. Currently, it is known that there are several signals within the channel backbone that serve as different checkpoints to deliver the protein to the plasma membrane; three of them are located after the Ca 2+ bowl in the regulator of conductance for K + (RCK) 2 domain, and another is located in the linker of RCK1 and RCK2 domains (Fig. 1, double arrows) . The former contains dihydrophobic motifs (YGDLF CKAL K; YNML CFGI, which is also a caveolin-1 interaction site; and DLIFCL) known to act as endoplasmic reticulum export signals [2, 5, 31, 88], while the latter contains an acidic cluster DDITD PKRI important for trafficking of other potassium channels [11, 44] .
In addition to intrinsic signals in the constitutive MaxiK protein, splice variation of the α-subunit can add or delete signal sequences modifying the channel localization by facilitating its retention/targeting to intracellular organelles like the endoplasmic reticulum [11, 26, 43, 97 , 98] and mitochondria [68] . A current challenge is to correlate the expression of specific splice variants to functional effects in native systems. In this respect, a 33-amino acid (aa) insert in transmembrane domain 1 containing CVLF trafficking signal that retains MaxiK in the endoplasmic reticulum of human embryonic kidney (HEK)293 T cells [97, 98] is increased in rat aging corpora, decreasing the channel surface expression [14] ; this property may contribute to aging-related changes in male sexual activity. Another example is a 27-aa-encoding exon, named ALCOREX (Fig. 1) , which produces channels in HEK293 cells that develop a transient sensitivity to alcohol that is higher and more persistent than the one observed for the insertless channel. Importantly, MaxiK channel activation by alcohol decays in~10 min which correlates with decreased ALCOREX expression in hypothalamo-neurohypophysial system explants exposed to alcohol [57] . This 27-aa insert also confers MaxiK channels its ability to be activated by arachidonic acid in growth hormone-secreting neurons, GH3 cells [34] .
Interestingly, intron-containing cytoplasmic mRNAs can also contribute to differences in channel expression levels and electrical activity in hippocampal neurons. This regulatory mechanism seems to provide a way for specific and local expression of MaxiK variants containing the 59-aa splice The overlay (c) shows colocalization of both proteins at the plasma membrane. d Super-resolution fluorescence images of Percoll-purified cardiac mitochondria [69] labeled for endogenous MaxiK α-subunit (mitoBK Ca ) with anti-MaxiK polyclonal antibody as described in [68] . Note distinct punctae of mitoBK Ca clusters. Images were acquired with a custom-made stimulation emission depletion (STED) microscope and pseudocolored for presentation. e, f Low-resolution confocal fluorescence images of purified mitochondria showing the specificity of the anti-MaxiK antibody (green) with only background signals in mitochondria from the knockout animal (Kcnma1
). The inset in f shows the same field double labeled with mitotracker (red). g Electron micrograph of the purified mitochondria preparation. Images were acquired at 0.0575 μm/pixel in (a, b, e, f) and at 0.0035 μm/pixel in (d) and were median filtered to reduce nonspecific background as described earlier [36] insert, STREX (Fig. 1) [7, 8] . Another regulatory mechanism for splice variant expression is via microRNA-9 (miR9), which can be upregulated by exposure to alcohol, immunodeficiency virus, and methamphetamines in the brain [57, 73] .
Membrane receptors and MaxiK channels
Biologically active substances like hormones, peptides, and lipids bind to membrane receptors triggering the activation of signalling molecules, in which many are kinases and phosphatases, to regulate multiple cellular events like contraction/ relaxation, cell proliferation, migration, and gene expression.
MaxiK channels are known to be functionally coupled to a variety of plasma membrane receptors like β-adrenergic receptors, ACh receptors, thromboxane A2 receptors, angiotensin II receptors, and to the G protein-coupled estrogen receptor 1. The functional coupling between MaxiK channels and membrane receptors usually uses intermediary proteins as G proteins and protein kinases that serve to transduce the signals received by the receptor to induce changes in channel activity, which can be inhibitory or excitatory depending on the receptor being stimulated or the hormonal status of the tissue. Recently, we uncovered a new transduction mechanism that utilizes direct protein-protein interactions between the thromboxane A2 receptor and the MaxiK channel that is independent of G protein activation and results in channel inhibition ("trans-inhibition") [35] .
The coupling between membrane receptors and MaxiK channels has been mostly studied in smooth muscle where muscle relaxants like β-adrenergic agents and estrogen induce MaxiK channel activation, and constrictors like acetylcholine, thromboxane A2, and angiotensin II result in channel inhibition. β2-Adrenergic receptor Early studies using bilayers and smooth muscle membranes showed that, after biochemical reconstitution, MaxiK channels can remain associated with β-adrenergic receptors in complex with G proteins pointing to stable and multiprotein interactions [64, 80] . Indeed, association of β2-adrenergic receptors and MaxiK channels has been demonstrated in the brain where they form a large macromolecular complex that includes protein kinase A (PKA), cytosolic A-kinase-anchoring protein (AKAP79/150), and the Ltype Ca 2+ channel [39] . Signalling mechanisms triggered by β2-adrenergic stimulation coupled to MaxiK activation have been studied in smooth muscle reconstituted in lipid bilayers and native cells and involve a membrane-delimited action of the α-subunit of Gs (G s α) on MaxiK channels as well as protein kinase A-mediated phosphorylation of the channel protein [27, 28, 51, 64] .
At the molecular level, the target site for PKA-mediated phosphorylation and activation of MaxiK channels is located in the RCK2 domain ( 866 RQPS* 869 , numbers are as in GenBank U11058) [51] . All four MaxiK α-subunits need to be phosphorylated at this site for the channel to be activated [76] . Evidence for a direct action of PKA on the channel protein is its ability to associate with MaxiK channels in the brain and the finding of the corresponding MaxiK phosphopeptide by proteomic analysis of immunopurified MaxiK also from the brain [39, 93]. Whether G s α interacts directly or forms a complex with MaxiK channels during channel activation is yet to be determined.
Interestingly, in nonpregnant myometrium, PKA can also cause inhibition of the MaxiK channel [56] , but the triggering membrane receptor/mechanism of this response is unknown. The molecular correlate of the PKA-inhibited MaxiK channel is a channel isoform that contains the STREX insert, which introduces an additional site for PKA-dependent phosphorylation [77] . Only a single STREX containing MaxiK α-subunit is required for PKA-dependent inhibition of channel activity, but the constitutive S 869 site must be dephosphorylated. Importantly, STREX is more abundant in nonpregnant myometrium and decreases with estrogen levels or pregnancy [102] explaining why, in nonpregnant myometrium, the majority of MaxiK channels are inhibited by PKA, whereas during midpregnancy, they are activated [56] , probably contributing to the maintenance of uterine quiescence for a successful pregnancy.
G protein-coupled estrogen receptor 1 The G protein-coupled estrogen receptor 1 (GPER1) is a recently discovered seventransmembrane receptor that is activated by estrogen. GPER1 plays a role in protecting the myocardium from ischemic insult by the activation of salvage kinase pathways and prevention of mitochondrial dysfunction [10, 15, 52]. Using its agonist G1, it has been shown that in coronary smooth muscle, GPER1 stimulation results in an increased MaxiK channel activity. This increased channel activity correlates with the relaxation of precontracted vessels by G1, which can be prevented by iberiotoxin, a MaxiK channel blocker [95] . Whether GPER1 and MaxiK channels interact closely with each other and which signalling pathways are used by GPER1 to modulate MaxiK channel activity are still open questions.
Muscarinic acetylcholine receptor M2 Initial evidence for acetylcholine receptor Gi-mediated inhibitory coupling to MaxiK channels was given in ileum and tracheal myocytes [13, 29] . However, a positive regulation has also been observed in canine tracheal myocytes [82] perhaps due to experimental conditions lacking GTP for proper coupling with G proteins. Although protein kinase C (PKC)-dependent inhibition of MaxiK channels is well known, its role as an inhibitory pathway induced by muscarinic M2 receptors was only addressed recently. In HEK cells as well as in tracheal myocytes, M2-mediated inhibition of MaxiK channels involves two mechanisms: (1) a membrane delimited Gβγ-mediated inhibition and (2) phospholipase C/PKC activation. Purified transducin Gβγ-mediated inhibition of MaxiK channel activity occurs independent of the activation of PLCβ isozymes, an increase in intracellular Ca 2+ concentration (from 0.3 µM to 1 µM), or the expression of MaxiK β1-subunit. Thromboxane A2 and angiotensin II receptors Thromboxane A2 prostanoid receptor (TPR) and angiotensin II type 1 receptor (AT1R) are G protein-coupled receptors (GPCRs) that play important roles in the development of vascular diseases such as heart angina, hypertension, and stroke due to the potent vasoconstrictor effects of their agonists, thromboxane A2 (TXA2) and angiotensin II (Ang II). In models of chronic vascular disease (e.g., hypertension, aortic regurgitation, atherosclerosis), TPR and AT1R gene ablation ameliorate disease symptoms (i.e., reduces blood pressure, cardiac hypertrophy, age-related progression of atherosclerosis) underscoring TPR and AT1R role in the pathogenesis of vascular disease and end-organ injury [17] [18] [19] . The functional interaction between these receptors and MaxiK channels was first made evident in experiments performed in lipid bilayers using coronary smooth muscle membrane vesicles, where thromboxane A2 as well as angiotensin II produced the inhibition of channel activity [65, 79] . The inhibition of MaxiK channel activity by angiotensin II presumably via AT1R was later observed in coronary myocytes [42] . Interestingly, in lipid bilayers, the inhibition of channel activity occurred without the addition of GTP, suggesting the involvement of a G protein-independent mechanism(s) [65, 79] . In line with this view and as mentioned earlier, we recently demonstrated that, in fact, TPR trans-inhibits MaxiK channels independent of G protein activation and via a mechanism that likely involves direct protein-protein interaction(s) between the receptor and the α-subunit of the channel. The MaxiK-TPR association utilizes the voltage-sensing conduction cassette of the channel α-subunit and the first intracellular loop and C-terminus of the receptor [35] . Figure 2a -c shows the colocalization of TPR and MaxiK channel α-subunit at the cell surface of human coronary myocytes.
The MaxiK channel-TPR association also includes the channel β1 regulatory subunit. Interestingly, the β1-subunit can independently associate with the receptor and the channel α-subunit, leading to the interesting hypothesis that β1-subunit could alter TPR function. Supporting this view, we found that β1 gene ablation produces blood vessels with twice the sensitivity to thromboxane A2, i.e., aortic strips showed a half maximal effective concentration (EC 50 ) to thromboxane A2 agonist, U46619, of 18 nM in the wild-type animals and an EC 50 of 9 nM in the β1 null mice [36] . Whether the β1-subunit also associates with other G protein-coupled receptors modifying their vasoconstricting/vasorelaxing potencies remains open to research. Also, a detailed study of how angiotensin II modifies MaxiK channel activity and whether AT1R is in close contact with the channel are topics that need scrutiny.
MaxiK and cell signalling
The coupling of MaxiK channels with seven-transmembrane receptors described above necessarily links MaxiK channels with cell signalling events, like activation of PKA and PKC. Moreover, direct protein-protein interactions have been found between the channel and focal adhesion kinase (FAK), and cytosolic phospholipase A2 (cPLA2), as well as regions in MaxiK channel necessary for association with PKA complexes and spleen tyrosine kinase (SyK) (Fig. 1, Table 1 ). This information in combination with recent proteomic data indicates that aside from its role in K + conduction, MaxiK channel may provide surface contact for a variety of proteins. In this view, MaxiK channel could act as "coordinator" or "linker" of signalling events.
Back in 2006, our review listed near 20 proteins that had been recognized as MaxiK α-subunit partners including plasma membrane and cytosolic proteins [41] . Today, this list has grown to the hundreds thanks to the establishment of the proteomics technology which has revealed that MaxiK channel is in complex with proteins not only at the plasma membrane or cytosol but also with proteins in organelles like the endoplasmic reticulum, nucleus, and mitochondria [24] . Interestingly, this approach has revealed the association of MaxiK channels with kinases relevant for cell death and survival, like Akt, glycogen synthase kinase-3β (GSK-3β), and phosphoinositide-dependent kinase-1 (PDK1) opening the intriguing possibility that MaxiK channels are also operators of cell life and dead. In addition, proteins that associate with MaxiK channels also include proteins linked to other cellular processes like metabolism, development, traffic, transport, and apoptosis (Fig. 3) [72] .
Many protein partners of MaxiK α-subunit have been detected/confirmed by coimmunoprecipitation, including Akt, GSK-3β, PDK1, Src, β2-adrenergic receptors, transient receptor potential canonical 1 (TRPC1), and its modulatory β1-and γ1-subunits among others [30, 41, 72, 91] . In these cases, a direct protein-protein interaction has not been established, and thus, indirect interactions cannot be strictly ruled out. Table 1 summarizes those proteins where direct protein-protein interactions have been reported or where MaxiK regions critical for protein associations have been identified. Although many of these interactions may be conserved in different cell types, a big challenge is to determine where, how, and when MaxiK channels interact with specific proteins for cell-specific functions and how failures in these interactions may lead to disease. [59] aa amino acid, ANKRA ankyrin-repeat family A protein, CoIP coimmunoprecipitation, cPLA2 cytosolic phospholipase A2, CRKL Crk-like protein, FAK focal adhesion kinase, ITAM immunoreceptor tyrosine-based activation motif, MAGI-1 membrane-associated guanylate kinase with inverted orientation protein 1, PKA protein kinase A, SH3 Src homology 3 a NCBI accession number b NCBI accession number is not given (amino acid numbers are as given in publications and may not coincide with template used in Fig. 1) c In these cases, a direct or indirect interaction has not been demonstrated
New views in MaxiK channel physiology and human disease The majority of studies have been directed to elucidate the physiological role of MaxiK channels expressed at the plasma membrane. However, MaxiK channels are also expressed in intracellular organelles like the mitochondria (Fig. 2d-g ), where their physiological role is beginning to be understood [24, 70] . These advances together with the linkage of MaxiK channel defects to human disease are highlighted below.
Role in mitochondria In cardiac mitochondria, pharmacological evidence indicates that MaxiK channel opening improves mitochondrial respiratory function and protects the heart from ischemic insult [4, 90]; in mitochondria from an astrocytoma cell line, their electrical activity is coupled to the respiratory chain [6] , and in pulmonary artery smooth muscle, 11,12-epoxyecidosatrienoic acid induced vasoconstriction, and mitochondrial depolarization has been linked to mitochondrial MaxiK (mitoBK Ca ) and its association with its β1-subunit [40] . The molecular correlate of mitoBK Ca was unknown until recently. As expected from its electrophysiological properties, we found that mitoBK Ca is encoded by the same gene (Kcnma1) encoding its plasma membrane counterpart and is formed by α-subunits of about 140 kDa. A C-terminal-spliced exon (named after the three last aa DEC) (Fig. 1) is required for the channel mitochondrial targeting. Using the MaxiK α-subunit knockout animal, we also confirmed that opening these channels with NS1619 protects the heart from ischemic insult. Mechanisms underlying this protection are enhanced performance of mitochondria and cardiac neurons [68, 87] . These findings together with the fact that MaxiK channels associate with the salvage kinase Akt and with GSK3β [72] , an integrator of signals whose phosphorylation prevents mitochondrial permeability transition, are strong arguments in favor of a role of MaxiK channels in cardioprotection and support a possible role in cell survival. superoxide dismutase, isocitrate dehydrogenase GSK-3β, Akt Na + /K + ATPase α-1 subunit, VPS28 Fig. 3 MaxiK channel potential functions uncovered by associated protein partners. Proteomic analyses have revealed that MaxiK channels associate not only with β and γ regulatory subunits but also with a large variety of proteins involved in diverse cellular functions [24, 72] . Note that proteomics cannot differentiate between direct (binding to the channel) or indirect interactors. We hypothesize that MaxiK α-subunit association with some proteins may be relatively steady like with regulatory α-and γ-subunits, while association with other partners (symbols) could be dynamic (incoming arrows); in both cases, interactions may be tissue specific and distinct depending on gender, age, and health status among others. Examples of MaxiK-associated proteins known to be involved (1) in signalling are 14-3-3 proteins, visinin-like protein 1 [72] , G proteincoupled receptors [35] , and kinases like PKA complex [75] and Akt (protein kinase B); (2) in traffic are tubulin [54] , calretinin [72] , the small GTPase Rab11b [71] , and actin [103] ; (3) in development/differentiation are prohibitin, Thy-1 membrane glycoprotein precursor [72] , and Syk [59] ; in transcription/translation are protein C14orf166 homolog and heterogeneous nuclear ribonucleoproteins A2/B1 [71] ; (4) in metabolism are mitochondrial precursors of fumarate hydratase and superoxide dismutase (Mn), and isocitrate dehydrogenase [72] ; (5) in apoptosis are glycogen synthase kinase-3β (GSK-3β) and Akt [72] ; and (6) in transport are Na + /K + ATPase alpha-1 subunit and vacuolar protein sorting-associated protein 28 homolog (VPS28) [72] 1. Brain disease. Paroxysmal movement disorder and generalized epilepsy was the first disorder correlated to a mutation in MaxiK channels. The mutation within the RCK1 domain neutralizes a negatively charged residue (D369-G). Out of 13 individuals affected with the disease, all carried the neutralizing mutation, which produces channels with higher sensitivity to Ca 2+ in heterologous expression. This feature would accelerate the repolarization of action potentials and would explain an increase in neuronal firing rate in the disease [16] . MaxiK channel dysfunction has also been associated with autism and mental retardation. These maladies have been related, in one case, to a chromosomal translocation event that resulted in silencing of one copy of the gene and, thus, reduced MaxiK expression, while in another case, a conserved mutation (A73-V) was found in the first intracellular loop [ linked to a polymorphism in an intronic sequence of MaxiK channel gene, and a haplotype with an additional polymorphism (in the fourth exon, C864T) has been linked to an increased risk of myocardial infarction in addition to systolic and general hypertension. However, the C864T haplotype corresponds to a synonymous single nucleotide polymorphism Phe229Phe, and the polymorphism in the intronic sequence did not generate a MaxiK channel isoform. Although there seem to be no functional effects, these mutations may serve as genetic markers of an increased risk for cardiovascular disease [78] . In line with the view that the MaxiK channel itself is not modified in human hypertension, a recent report from Chinese patients with hypertension shows that this was the case; instead, in this population, MaxiK channel regulatory β1-subunit was the one that was reduced, causing the expected decrease in the channel Ca 2+ sensitivity and voltage dependence of activation [94] . 4. Cancer. MaxiK channel overexpression has been correlated with the malignancy of human gliomas; accordingly, its inhibition reduced glioma cell growth. A key factor in the development of glioma seems to be a distinctive 34-aa splice variant insert (Fig. 1, arrow, sequence in red) , which, to our knowledge, has not been detected in healthy cells. This 34-aa insert is in tandem with a previously reported 29-aa spliced exon (Fig. 2 , arrow, sequence in gray) producing channels with higher Ca 2+ sensitivity [38, 85] . The glioma MaxiK isoform (gBK) is expressed at the cell membrane, mitochondria, Golgi, and endoplasmic reticulum and is also found in other types of tumor cell lines derived from duodenal, colon, hepatocellular, and pancreatic cancers. Importantly, this molecular information has provided the tools to generate gBK peptidespecific cytotoxic T lymphocytes and to kill cells expressing gBK [20] .
Role in human disease
Amplification of MaxiK channel gene is another mechanism that has been correlated with cancers, specifically with prostate and breast cancers. Obviously, it is important to elucidate the mechanisms triggered by this genomic amplification, as breast cancers associated with MaxiK gene amplification are those of high tumor grade, high cell proliferation, and poor prognosis [9, 53] . Moreover, it would be relevant to determine the molecular composition of MaxiK in breast cancer cells and to determine whether it contains the gBK isoform.
Concluding remarks
From the stand point of cell signalling, it is intriguing that a large variety of molecules can form complexes with MaxiK channels underscoring the necessity to understand the dynamics of these connections and their physiological consequences. One highlight in this regard is the interaction of MaxiK channels and G protein-coupled receptors with opposite functions in smooth muscle, relaxation and constriction. When do these interactions take place and are they affected in disease or during aging are few of the questions that would be important to address in the future.
At the molecular level, the soluble C-terminus of the channel α-subunit represents two thirds of the protein and, thus, may provide a significant surface contact for direct proteinprotein interactions. Future studies need to identify which of the hundreds of proteins found by proteomics to associate with MaxiK channel α-subunit may serve as scaffolds directly binding to the channel and, thus, facilitating the association with other proteins and/or relay of signals to other signalling clusters.
Finally, the increasing evidence about the role of MaxiK channels in human disease including obesity and cancer offers opportunities to understand the mechanisms of human disease and to design new strategies for their potential cure. 
